Sfoglia per Autore
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy
2004-01-01 Offidani, M; Corvatta, L; Marconi, M; Malerba, L; Mele, A; Olivieri, Attilio; Brunori, M; Catarini, M; Candela, M; Capelli, D; Montanari, M; Rupoli, S; Leoni, Pietro
Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias
2004-01-01 Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio
Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients
2004-01-01 Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro
Reduced-intensity conditioning (RIC) followed by allogeneic transplantation in relapsed lymphomas: Evidence for Graft-Versus-Lymphoma effect in low and high grade histologies, but not in Hodgkin disease
2004-01-01 Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Farina, L; Rizzo, E; Milni, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, Am; Tarella, C.
Molecular monitoring of minimal residual disease after reduced-intensity conditioning and allogeneic stem cell transplantation in relapsed chronic lymphocytic leukaemia
2004-01-01 Farina, L; Soligo, D; Rizzo, E; Dodero, A; Locasciulli, A; Scime, R; Santoro, A; Gianni, Am; Tarella, C; Lucesole, M; Olivieri, Attilio; Corradini, P.
Combination thalidomide, doxil and dexamethasone as salvage therapy for patients relapsed after tandem autotransplant
2004-01-01 Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Mele, A; Galieni, P; Centurioni, R; Alesiani, F; Candela, M; Leoni, Pietro
Molecular remission can be attained in relapsed or refractory chronic lymphocytic leukemia (CLL) and follicular lymphomas after reduced intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT).
2004-01-01 Farina, L; Carrabba, M; Dodero, A; Rizzo, E; Zorzan, E; Ciceri, F; Locasciulli, A; Olivieri, Attilio; Rambaldi, A; Tarella, C; Santoro, A; Patriarca, F; Bacigalupo, A; Corradini, P.
Salvage treatment with pegylated liposomal doxorubicin (Caelyx), cyclophosphamide-rituximab (DC-R) plus GM-CSF in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation failure
2004-01-01 Olivieri, Attilio; Montanari, M; Spitaleri, L; Capelli, D; Lucesole, M; Scortechini, I; Offidani, M; Gini, G; Troiani, E; Leoni, Pietro
Reduced-intensity conditioning followed by allografting in patients with advanced haematological malignancies older than 60 years
2004-01-01 Olivieri, Attilio; Lucesole, M; Cecchi, S; Dodero, A; Ciceri, F; Bregni, M; Tarella, C; Falda, M; Locasciulli, A; Scime, R; Patriarca, F; Casini, M; Bacigalupo, A; Corradini, P.
Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies
2004-01-01 Corradini, P; Zallio, F; Mariotti, J; Bregni, M; Ciceri, F; Bacigalupo, A; Dodero, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Majolino, I; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio
High dose chemotherapy (HD CHT) followed by autologous PBPC transplant in elderly ANLL patients.
2004-01-01 Capelli, D; Troiani, E; Discepoli, G; Poloni, Antonella; Montanari, M; Catarini, M; Centurioni, R; Alesiani, F; Brunori, M; Lucesole, M; Leoni, Pietro; Olivieri, Attilio
Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease
2004-01-01 Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R.
Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
2004-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P.
Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO
2004-01-01 Alessandrino, Ep; La Nasa, G; Malcovati, L; De Fabritiis, P; Bregni, M; Mazza, P; Di Bartolomeo, P; Locasciulli, A; Scime, R; Mordini, N; Olivieri, Attilio; Deliliers, Gl; Bacigalupo, A.
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders.
2004-01-01 Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Troiani, M; Offidani, M; Poloni, Antonella; Masia, Mc; Raggetti, Gm; Leoni, Pietro
Effect of age and previous autologous transplant on treatment-related mortality and GVHD in 140 patients treated with reduce-intensity conditioning and allograft for advanced hematological malignancies.
2004-01-01 Corradini, P; Zallio, F; Mariotti, J; Valagussa, P; Dodero, A; Bregni, M; Ciceri, F; Bacigalupo, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio
Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma.
2004-01-01 Offidani, M; Corvatta, L; Marconi, M; Olivieri, Attilio; Catarini, M; Mele, A; Brunori, M; Candela, M; Malerba, L; Capelli, D; Montanari, M; Leoni, Pietro
Infliximab treatment for steroid-refractory acute graft-versus-host disease.
2004-01-01 Patriarca, F; Sperotto, A; Damiani, D; Morreale, G; Bonifazi, F; Olivieri, Attilio; Ciceri, F; Milone, G; Cesaro, S; Bandini, G; Dini, G; Corradini, P; Fanin, R.
Rituximab-supplemented high-dose sequential chemotherapy (HDS) has superior response rate and event-free survival (EFS) compared to R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: Results from a multicenter randomized GITMO trial.
2005-01-01 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Am; Musso, M; Pulsoni, A; Olivieri, Attilio; Pavone, E; Pogliani, E; Scalabrini, Dr; Gallamini, A; Callea, V; Mantoan, B; Boccadoro, M; Majolino, I; Corradini, P; Gianni, Am; Tarella, C.
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD.
2005-01-01 Olivieri, Attilio; SVEGLIATI BARONI, Silvia; N., Campelli; Luchetti, MICHELE MARIA; S., Trappolini; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy | 1-gen-2004 | Offidani, M; Corvatta, L; Marconi, M; Malerba, L; Mele, A; Olivieri, Attilio; Brunori, M; Catarini, M; Candela, M; Capelli, D; Montanari, M; Rupoli, S; Leoni, Pietro | |
| Reduced-intensity conditioning followed by allogeneic transplantation: poor outcome in secondary versus de novo acute myeloid leukaemias | 1-gen-2004 | Corradini, P; Milani, R; Dodero, A; Tarella, C; Bandini, G; Locasciulli, A; Bernardi, M; Lucesole, M; Busca, A; Soligo, D; Gianni, Am; Bregni, M; Olivieri, Attilio | |
| Autologous transplant in over 60 patients with lymphoproliferative disorders: a single-centre experience in 63 patients | 1-gen-2004 | Capelli, D; Olivieri, Attilio; Scortechini, A; Montanari, M; Lucesole, M; Brunori, M; Troiani, E; Gini, G; Masia, M; Pasquini, R; Balducci, F; Leoni, Pietro | |
| Reduced-intensity conditioning (RIC) followed by allogeneic transplantation in relapsed lymphomas: Evidence for Graft-Versus-Lymphoma effect in low and high grade histologies, but not in Hodgkin disease | 1-gen-2004 | Corradini, P; Dodero, A; Bregni, M; Olivieri, Attilio; Farina, L; Rizzo, E; Milni, R; Scime, R; Rambaldi, A; Bonifazi, F; Patriarca, F; Locasciulli, A; Bacigalupo, A; Gianni, Am; Tarella, C. | |
| Molecular monitoring of minimal residual disease after reduced-intensity conditioning and allogeneic stem cell transplantation in relapsed chronic lymphocytic leukaemia | 1-gen-2004 | Farina, L; Soligo, D; Rizzo, E; Dodero, A; Locasciulli, A; Scime, R; Santoro, A; Gianni, Am; Tarella, C; Lucesole, M; Olivieri, Attilio; Corradini, P. | |
| Combination thalidomide, doxil and dexamethasone as salvage therapy for patients relapsed after tandem autotransplant | 1-gen-2004 | Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Mele, A; Galieni, P; Centurioni, R; Alesiani, F; Candela, M; Leoni, Pietro | |
| Molecular remission can be attained in relapsed or refractory chronic lymphocytic leukemia (CLL) and follicular lymphomas after reduced intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT). | 1-gen-2004 | Farina, L; Carrabba, M; Dodero, A; Rizzo, E; Zorzan, E; Ciceri, F; Locasciulli, A; Olivieri, Attilio; Rambaldi, A; Tarella, C; Santoro, A; Patriarca, F; Bacigalupo, A; Corradini, P. | |
| Salvage treatment with pegylated liposomal doxorubicin (Caelyx), cyclophosphamide-rituximab (DC-R) plus GM-CSF in B-diffuse large cell lymphoma (B-DLCL) after autologous stem cell transplantation failure | 1-gen-2004 | Olivieri, Attilio; Montanari, M; Spitaleri, L; Capelli, D; Lucesole, M; Scortechini, I; Offidani, M; Gini, G; Troiani, E; Leoni, Pietro | |
| Reduced-intensity conditioning followed by allografting in patients with advanced haematological malignancies older than 60 years | 1-gen-2004 | Olivieri, Attilio; Lucesole, M; Cecchi, S; Dodero, A; Ciceri, F; Bregni, M; Tarella, C; Falda, M; Locasciulli, A; Scime, R; Patriarca, F; Casini, M; Bacigalupo, A; Corradini, P. | |
| Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies | 1-gen-2004 | Corradini, P; Zallio, F; Mariotti, J; Bregni, M; Ciceri, F; Bacigalupo, A; Dodero, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Majolino, I; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio | |
| High dose chemotherapy (HD CHT) followed by autologous PBPC transplant in elderly ANLL patients. | 1-gen-2004 | Capelli, D; Troiani, E; Discepoli, G; Poloni, Antonella; Montanari, M; Catarini, M; Centurioni, R; Alesiani, F; Brunori, M; Lucesole, M; Leoni, Pietro; Olivieri, Attilio | |
| Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease | 1-gen-2004 | Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R. | |
| Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma | 1-gen-2004 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P. | |
| Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO | 1-gen-2004 | Alessandrino, Ep; La Nasa, G; Malcovati, L; De Fabritiis, P; Bregni, M; Mazza, P; Di Bartolomeo, P; Locasciulli, A; Scime, R; Mordini, N; Olivieri, Attilio; Deliliers, Gl; Bacigalupo, A. | |
| Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. | 1-gen-2004 | Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Troiani, M; Offidani, M; Poloni, Antonella; Masia, Mc; Raggetti, Gm; Leoni, Pietro | |
| Effect of age and previous autologous transplant on treatment-related mortality and GVHD in 140 patients treated with reduce-intensity conditioning and allograft for advanced hematological malignancies. | 1-gen-2004 | Corradini, P; Zallio, F; Mariotti, J; Valagussa, P; Dodero, A; Bregni, M; Ciceri, F; Bacigalupo, A; Lucesole, M; Patriarca, F; Rambaldi, A; Scime, R; Bandini, G; Gianni, Am; Tarella, C; Olivieri, Attilio | |
| Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma. | 1-gen-2004 | Offidani, M; Corvatta, L; Marconi, M; Olivieri, Attilio; Catarini, M; Mele, A; Brunori, M; Candela, M; Malerba, L; Capelli, D; Montanari, M; Leoni, Pietro | |
| Infliximab treatment for steroid-refractory acute graft-versus-host disease. | 1-gen-2004 | Patriarca, F; Sperotto, A; Damiani, D; Morreale, G; Bonifazi, F; Olivieri, Attilio; Ciceri, F; Milone, G; Cesaro, S; Bandini, G; Dini, G; Corradini, P; Fanin, R. | |
| Rituximab-supplemented high-dose sequential chemotherapy (HDS) has superior response rate and event-free survival (EFS) compared to R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: Results from a multicenter randomized GITMO trial. | 1-gen-2005 | Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Am; Musso, M; Pulsoni, A; Olivieri, Attilio; Pavone, E; Pogliani, E; Scalabrini, Dr; Gallamini, A; Callea, V; Mantoan, B; Boccadoro, M; Majolino, I; Corradini, P; Gianni, Am; Tarella, C. | |
| Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. | 1-gen-2005 | Olivieri, Attilio; SVEGLIATI BARONI, Silvia; N., Campelli; Luchetti, MICHELE MARIA; S., Trappolini; Poloni, Antonella; Leoni, Pietro; Gabrielli, Armando |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile